Eric Dobmeier
Director/Board Member presso ATARA BIOTHERAPEUTICS, INC.
Patrimonio netto: 390 948 $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Srini Akkaraju Akkaraju | M | 56 |
Chinook Therapeutics U.S., Inc.
 Chinook Therapeutics U.S., Inc. Information Technology ServicesTechnology Services Chinook Therapeutics U.S., Inc. operates as a development stage company. The company is headquartered in Seattle, WA. | 21 anni |
| Eric Hyllengren | M | - | 6 anni | |
| Michelle Griffin | F | 58 | 5 anni | |
| Daniel Welch | M | 66 | 18 anni | |
| Pascal Touchon | M | 61 | 5 anni | |
| Carol Gallagher | M | 59 | 11 anni | |
| Jerel Davis | M | 47 |
Chinook Therapeutics U.S., Inc.
Chinook Therapeutics U.S., Inc. Information Technology ServicesTechnology Services Chinook Therapeutics U.S., Inc. operates as a development stage company. The company is headquartered in Seattle, WA. | 6 anni |
| Raymond Stevens | M | 60 | 5 anni | |
| Kenneth Hoberman | M | 59 | 11 anni | |
| Joanne Waldstreicher | M | 63 | 2 anni | |
| Jun Yoon | M | 46 | 5 anni | |
| Katey Owen | M | 55 | 3 anni | |
| Stacy Taylor | F | 64 | 5 anni | |
| Ameet Mallik | M | 51 | 3 anni | |
| Maria Grazia Roncarolo | M | 69 | 4 anni | |
| Jeffrey Levitt | M | - | 6 anni | |
| Ted Love | M | 65 | 1 anni | |
| Ramy Farid | M | 59 | 5 anni | |
| David Gionco | M | 63 | 10 anni | |
| Michael Pellini | M | 58 | 6 anni | |
| Matthew Fust | M | 59 | 10 anni | |
| Sharon Tetlow | F | 64 | 2 anni | |
| William Heiden | M | 64 | 9 anni | |
| Dan Maziasz | M | - | 6 anni | |
| Tony Peng | M | - | - | |
| Ying Li Ma | M | 50 | 2 anni | |
| Xi Chen Lin | M | 50 | 5 anni | |
| Natasha Hernday | F | 52 | 13 anni | |
| Mark Bach | M | 67 | 3 anni | |
| Jill Henrich | F | - | - | |
| Francis Lo | M | 43 | 5 anni | |
| Lani Ibarra | F | - | - | |
| Anhco Nguyen | M | 51 | 3 anni | |
| K. Murugan | M | 49 | 4 anni | |
| Karen S. Wright | F | 69 | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| R. Adams | M | 57 | 3 anni | |
| Isaac E. Ciechanover | M | 53 | 7 anni | |
| Felix Baker | M | 55 | 20 anni | |
| Mina Kim | F | 50 | 1 anni | |
| Darren Cline | M | 59 | 9 anni | |
| Edmon R. Jennings | M | 75 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 6 anni |
| Joshua Brumm | M | 46 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 4 anni |
| Vaughn Himes | M | 63 | 14 anni | |
| Joseph Newell | M | 54 | 5 anni | |
| Colin Hislop | M | 66 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 1 anni |
| Tony Sun | M | 52 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 5 anni |
| Andris A. Zoltners | M | 78 | 11 anni | |
| John Orwin | M | 59 | 9 anni | |
| John Craighead | M | - | - | |
| Andrew King | M | 44 | 4 anni | |
| Charles Sang | M | 56 | 7 anni | |
| Nancy Hill | F | 60 | 8 anni | |
| Kirk D. Schumacher | M | - | 11 anni | |
| David Goel | M | 54 | 5 anni | |
| Larry K. Benedict | M | 63 | 8 anni | |
| Robert Azelby | M | 56 | - | |
| Marcos Milla | M | 61 | 1 anni | |
| Charles Romp | M | - | 13 anni | |
| Christopher Boerner | M | 53 | 5 anni | |
| Beth Seidenberg | M | 67 | 11 anni | |
| Dolca Thomas | M | 53 | 3 anni | |
| James Kyle Bryan | M | - | - | |
| Shane Ward | M | 49 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 3 anni |
| Mahesh Krishnan | M | 53 | - | |
| Tina Gullotta | F | 50 | 4 anni | |
| Roy Baynes | M | 69 | 4 anni | |
| Shay Shemesh | M | 41 | 5 anni | |
| Kevin Haas | M | 59 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 4 anni |
| Douglas Williams | M | 66 | 3 anni | |
| Franklin Berger | M | 74 | 10 anni | |
| Jean Liu | F | 55 | 9 anni | |
| Leslie Trigg | F | 53 | - | |
| Kevin Conroy | M | 58 | 4 anni | |
| Obi Greenman | M | 57 | 13 anni | |
| Heather Turner | F | 51 | 3 anni | |
| J. Buchi | M | 69 | 4 anni | |
| Eckard Weber | M | 73 | 2 anni | |
| David Gryska | M | 68 | 18 anni | |
| Joel Marcus | M | 76 | 6 anni | |
| H. Perry Fell | M | - | 7 anni | |
| Kenneth Lee | M | 76 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | - |
| John McLaughlin | M | 72 | 9 anni | |
| John F. McGrath | M | 59 | 6 anni | |
| Nancy Simonian | M | 63 | 11 anni | |
| Stephen Hall | M | 73 | - | |
| Ross Haghighat | M | 60 | 14 anni | |
| Robert Hoffman | M | 58 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | - |
| John Varian | M | 64 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 4 anni |
| Ronald Renaud | M | 55 | 2 anni | |
| Bruce J. Seeley | M | 59 | 3 anni | |
| Jonathan Drachman | M | 62 | 14 anni | |
| Elaine Waller | M | 72 | 10 anni | |
| Todd Simpson | M | 63 | 18 anni | |
| Dennis Benjamin | M | - | 3 anni | |
| Brandi Robinson | F | - | 2 anni | |
| Jorge Cerda Lucero | M | - | - | |
| Walter Moos | M | 69 | 4 anni | |
| Amy P. Sing | M | 65 | 4 anni | |
| Andrew Sandler | M | 58 | 4 anni | |
| Iqbal S. Grewal | M | - | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Eric Dobmeier
- Contatti personali
